Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;26(7):835-41.
doi: 10.1080/09540121.2013.861573. Epub 2013 Nov 28.

Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India

Affiliations

Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India

Venkatesan Chakrapani et al. AIDS Care. 2014.

Abstract

India's National AIDS Control Organization provides free antiretroviral treatment (ART) to people living with HIV (PLHIV), including members of marginalized groups such as injecting drug users (IDUs). To help inform development of interventions to enhance ART access, we explored barriers to free ART access at government ART centers for IDUs living with HIV in Chennai by conducting three focus groups (n = 19 IDUs) and four key informant interviews. Data were explored using framework analysis to identify categories and derive themes. We found interrelated barriers at the family and social, health-care system, and individual levels. Family and social level barriers included lack of family support and fear of societal discrimination, as well as unmet basic needs, including food and shelter. Health-care system barriers included actual or perceived unfriendly hospital environment and procedures such as requiring proof of address and identity from PLHIV, including homeless IDUs; provider perception that IDUs will not adhere to ART, resulting in ART not being initiated; actual or perceived inadequate counseling services and lack of confidentiality; and lack of effective linkages between ART centers, needle/syringe programs, and drug dependence treatment centers. Individual-level barriers included active drug use, lack of self-efficacy in ART adherence, low motivation to initiate ART stemming from a fatalistic attitude, and inadequate knowledge about ART. These findings indicate that to facilitate IDUs gaining access to ART, systemic changes are needed, including steps to make the environment and procedures at government ART centers more IDU-friendly and steps to decrease HIV- and drug use-related stigma and discrimination faced by IDUs from the general public and health-care providers. Housing support for homeless IDUs and linkage of IDUs with drug dependence treatment are also essential.

Keywords: AIDS; HIV; India; access to health care; antiretroviral treatment; injecting drug users.

PubMed Disclaimer

References

    1. Abraham KK, D’Costa C, Shunmugam M, Chakrapani V. India. In: In International Treatment Preparedness Coalition (ITPC), editor. Missing the target #5: Improving AIDS drug access and advancing health care for all. San Francisco, CA: The Tides Center; 2007. pp. 75–76. Retrieved from http://www.opensocietyfoundations.org/sites/default/files/missing_200712....
    1. Aceijas C, Oppenheimer E, Stimson GV, Ashcroft RE, Matic S, Hickman M. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the “Treating 3 million by 2005. Making it happen. The WHO strategy” (“3 by 5”) Addiction. 2006;101:1246–1253. - PubMed
    1. Aday LA, Andersen R. A framework for the study of access to medical care. Health Services Research. 1974;9:208–220. - PMC - PubMed
    1. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2001;26:435–442. - PubMed
    1. Bassetti S, Battegay M, Furrer H, Rickenbach M, Flepp M, Kaiser L, Sudre P. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes. 1999;21:114–119. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources